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The chemical contents and in vitro antibacterial effects of the n-butanol column fractions, stem bark 
methanol extracts of Bauhinia rufescens Lam. were evaluated in Gram-positive and Gram-negative bacteria 
using disc diffusion technique. The n-butanol soluble portion from the stem bark methanol extract was 
successively eluted to afford 10 pooled fractions by comparison of TLC chromatograms. The bioactive fraction 
(fraction D) was further chromatographed using the bioassay guided protocol to afford 4 sub-fractions from 
which a pure compound was isolated and characterized using spectral studies as: (4S, 6R)-(Z)-6-(β-D-
glucopyranosyloxy)-4-hydroxy-2-cyclohexenyl-∆1,α-acetonitrile–a cyclohexenyl cyano methylene known 
commonly as menisdaurin. Test bacteria were Bacillus subtilis, Corynaebacterium spp., Escherichia coli and 
Shigella dysenteriae. The diameters of inhibition zone on the Gram-positive bacteria was found in the range 
from11.83±0.17 (n-butanol Fraction D) to 17.33±0.67 (Fraction D2-8); while on Gram-negative organism the 
values ranged from 11.50±0.29 (n-butanol Fraction D) to 19.67±0.33 (Fraction D2-8). The activity index (AI) 
showed that Fraction D2-8 (51.18%) and Compound I [menisdaurin] (127.36%) was highly sensitive to 
Corynaebacterium spp. and E. coli when computed with Erythromycin and Gentamicin respectively. Highest 
AI was exhibited by Fraction D2-8 (93.89%) against S. dysenteriae when computed with ciprofloxacin. In 
continuation of our chemical studies and search for bi active compounds from medicinal plants; this work, 
therefore, was aimed at characterizing and testing the antibacterial efficacy of the isolated compound in order 
to further confirm our earlier reports on use of this part of B. rufescens in some parts of Northern Nigeria as a 
treatment against diarrhoea and dysentery. This is the first report of the isolation and antibacterial activity of 
menisdaurin from B. rufescens. 
© 2013 International Formulae Group. All rights reserved. 
 




Medicinal plants, being the reservoir 
for drug and lead compounds for many 
therapeutic agents, are relatively safer and 
more affordable than synthetic alternatives 
(Akah et al., 2007; Iwu et al., 1999). There is 
global resurgence in the use of herbal 
preparations especially in some developing 
countries like Nigeria. These preparations are 
gradually sandwich into the primary and 
secondary health care delivery systems (El-
Mahmood and Ameh, 2007). It has been 
estimated that more than 50% of Western 
drugs originated from plant materials 





(Robbers et al., 1996). Several plants are 
indicated in folk and other traditional systems 
of medicines as anti-infective agents (El-
Mahmood and Ameh, 2007). In recent times, 
there have been increases in antibiotic 
resistant strains of clinically important 
pathogens, which have led to the emergence 
of new bacterial strains that are multi-resistant 
(WHO, 2001, Aibinu et al., 2003; Aibinu et 
al., 2004; Odunayo et al., 2007). The non-
availability and high cost of new generation 
antibiotics with limited effective span have 
resulted in increase in morbidity and mortality 
among the populace (Williams, 2000). 
Therefore, it is pertinent to continue research 
on drugs from medicinal plant sources. 
Bauhinia rufescens Lam is a scandent shrub of 
the family Leguminosae sub-family 
Caesalpiniodeae (FAO-UNEP, 1983; Burkill, 
1995); it is deciduous in the drier area and an 
evergreen in wetter areas. It has wide array of 
medicinal values; the stem bark is used as 
cure for diarrhoea, dysentery, leprosy and to 
reduce fever (Burkill, 1995). In continuation 
of our interest in chemical studies and search 
for bioactive compounds from medicinal 
plants and to further confirm our earlier work 
on the crude extracts and partitioned portions 
of the stem bark of B. rufescens (Usman et al., 
2009a,b,c). This work, therefore, was aimed at 
isolating and characterizing bioactive 
compound using chromatographic/spectral 
studies and then testing its efficacy against 
test bacteria using the hole-in-plate disc 
diffusion technique.  
 
MATERIALS AND METHODS 
Collection and identification of plant 
The plant material (voucher number - 
#003/2008; Bauhinia rufescens Lam) was 
collected from Gathla village (Long. 13o 
31.369′E, Lat. 11o 00.562′N), Gwoza - Borno 
State, Nigeria in June, 2008. The herbarium 
specimen was identified by Prof. S.S Sanusi 
of Biological Science Department, and the 
voucher specimen was deposited at the Post 
graduate Research Laboratory, Department of 
Chemistry, University of Maiduguri, Nigeria 
for reference. The stem bark of the plant was 
air-dried under shade and pulverised into fine 
powder. 
 
Extraction of plant materials 
The concentrated n-butanol 
fractionated portion obtained from the crude 
methanol stem bark extract of B. rufescens 
(Usman et al., 2009a), was kept at 4 oC till 
use. The n-butanol Fraction D was subjected 
to detailed purification protocol using the 
column chromatography utilizing silica gel as 
adsorbent and in vitro antimicrobial 
susceptiblity analysis evaluated accordingly. 
 
Test bacteria 
Test bacteria were: Bacillus subtilis, 
Corynaebacterium spp. Escherichia coli and 
Shigella dysenteriae. The standard antibiotics 
disc used were Ciprofloxacin (5 µg/disc); 
Erythromycin (5 µg/disc) and Gentamicin (10 
µg/disc). These bacteria were clinical isolates 
obtained from the Department of Medical 
Microbiology and Department of Veterinary 
Medicine, University of Maiduguri, 
Maiduguri-Nigeria. 
 
Antimicrobial susceptibility test 
The n-butanol Fraction D portion and 
sub-fractions of the stem bark extract of B. 
rufescens  was subjected to antimicrobial 
evaluation on two Gram-positive and two 
Gram-negative strains using the hole-in-plate 
disc diffusion technique as described by 
Forbes et al. (1990); Vlietinck et al. (1995); 
Usman et al. (2007). Our earlier report 
revealed that fraction D contains cardenolides, 
cardiac and cyanogenic glycosides, 
flavonoids, resins, tannins (Usman et al., 
2012). 
The n-butanol Fraction D portion and 
sub-fractions of the stem bark extract of B. 
rufescens  was subjected to antimicrobial 
evaluation on two Gram positive and two 
Gram negative strains using the hole-in-plate 
disc diffusion technique as described by 
Forbes et al. (1990); Vlietinck et al. (1995); 
Usman et al. (2007). Our earlier report 





revealed that fraction D contains cardenolides, 
cardiac and cyanogenic glycosides, 
flavonoids, resins, tannins (Usman et al., 
2012). 
The extracts were made in three 
different stock concentrations of 1.5625, 
3.125 and 6.25 mg/ml by dissolving 0.015625, 
0.03125 and 0.0625 g respectively into 10 ml 
each of 85% methanol in distilled water (v/v) 
– as vehicle. The bacteria were maintained on 
agar slants until use. The inocula were then 
prepared by subjecting the test bacteria in 
nutrient broth and incubated for 24 hours at 37 
oC. One millilitre of the diluted cultures was 
inoculated into 19 ml sterile molten nutrient 
agar (48 oC) and poured into sterile Petri 
dishes. Afterwards, holes of 9 mm internal 
diameter were bored onto the solidified and 
inoculated nutrient agar plates using sterilized 
number VI cork borer. All the holes were 
filled with equal volumes of 0.1 ml of 
different concentration to afford 0.156, 
0.3125, 0.625 mg/hole.  Standard discs were 
placed on bacterial-inoculated nutrient agar 
plate; the extracts were allowed to diffuse into 
the agar for an hour. Thereafter, the plates 
were incubated overnight at 37 oC. The extract 
was independently tested in triplicate. 
Diameters of inhibition zones (DIZ) >10 mm 
exhibited by plant extracts were considered 
active (Usman et al., 2007). 
Activity index (AI) 
This was evaluated as 100 x diameters 
of inhibition zone of extract ÷ diameters of 
inhibition zone of the standard antibiotic 
(expressed as %) (Shahidi, 2004). 
Percent actvitiy (PA) 
This was calculated as 100 x number of 
susceptible strains to a specific extract ÷ total 
number of tested bacterial strains. This was 
expressed as % Gram positive, % Gram 
negative and %T as total activity against both 
Gram positive and Gram negative (Shahidi, 
2004). 
Bacterial susceptibility index (BSI) 
This was calculated as 100 x number of 
extracts effective against each bacterial strain 
÷ number of total samples (expressed as %) 
(Shahidi, 2004). 
Average percent of bacterial susceptibility 
(APBS) 
This was determined as sum of % 
activities (%G+, %G-, or %T) ÷ number of 
total samples, this represents overall 
susceptibility of each group of bacterial strain 
(Shahidi, 2004). 
Spectral intensity index (SII) 
This was determined as: Mean 
diameters of inhibition zones (mm) of all 
sensitive bacterial strains to a specific sample 
x %T ÷ 100 (Shahidi, 2004).  
 
Statistical analysis 
The statistical analysis involved the 
determination of mean differences among the 
zone of inhibition exhibited by the extracts 
against each organism and the standard 
antibiotics analysed using One-way ANOVA 
with Student-Newman-Keuls Multiple 
comparisons test performed using GraphPad 
InStat (GraphPad Software, 1998). 
 
Chromatographic separation of the n-
butanol portion 
The crude methanol extract was 
partitioned with various organic solvents as 
mentioned earlier (Usman et al., 2009b). The 
most susceptible portion (n-butanol fraction) 
was subjected to column chromatographic 
separation which afforded 10 pooled fractions 
coded A-J as reported earlier (Usman et al., 
2012). Fraction D was observed to be active 
and then subjected to further purification 
protocol. 
Isolation of compound I 
About 15.0 g of Sephadex LH-20 
(Amersham Biosciences, Sweden) were 
packed manually into a column of 45 cm x 1.4 
cm i.d. The sephadex LH-20 was allowed to 
swell in MeOH overnight and cautiously filled 
into the column using a glass funnel. The gel 
was then allowed to settle and pack for 24 hrs. 
The air bubbles were avoided and care was 
taken not to dry the column. About 1.5 g of n-
butanol fraction D was mounted on the 





already equilibrated sephadex-fixed column. 
A total of 18 sub-fractions were generated and 
pooled in four relative groups: FD1, FD2-8, 
FD9-11 and FD12-18. FD1 (35 mg) and FD2-
8 (80 mg) showed potent antimicrobial 
activities and thus separated further for 
isolation of the active compound(s). 
Continuous re-purification of FD2-8 by 
repetitive sephadex column chromatography 
and PTLC revealed D2-8:1 (56 mg) as pure 
colourless crystalline plates; the M.P. was 
found to be 170-172 oC uncorrected. The 
isolated compound coded ‘Compound I’ was 
characterized using various analytical 
techniques: {IR, UV-Vis, NMR [1HMNR, 
COSY, 13CNMR, DEPT, NOESY, HMBC, 
HMQC]} and was soluble in methanol and 
ethanol, but insoluble in petroleum ether, 
benzene and chloroform.  
 
RESULTS 
Characterization of compound I 
The structure of compound I was 
elucidated and characterized using various 
analytical techniques. The Infra-red (IR) 
spectrum reveal strong absorption band 
around 2200 cm-1. The UV absorption 
maximum at 259.0 nm.   
The HNMR spectrum showed 
diagnostic peak for glucose at 4.571 ppm, a 
series of doublet-like signals centered at 
3.336, 3.394, 3.287, 3.663, 3.881 ppm were 
equally found; two doublets appeared at 6.289 
and 6.202 ppm and also at 5.512 ppm. Other 
signals were found at 4.913, 4.371, 2.252 and 
2.033 ppm. The COSY spectrum showed the 
H-H couplings; the proton at 4.371 ppm 
coupled to protons at 2.033 and 2.252 ppm 
among others.  
The 13CNMR spectrum of the 
compound I in methanol exhibited fourteen 
carbon atoms approximately equal in height 
with some having characteristic chemical 
shifts equivalence. Definitive peaks were 
observed at 36.14, 63.11, 65.42, 71.73, 72.66, 
74.55, 78.02, 78.13, 96.86 ppm. Others 
downfield peaks were at 101.59, 118.20, 
127.85, 140.65 and 157.26 ppm. The  DEPT 
spectrum revealed that peaks at 157.26 ppm 
and 118.20 ppm  lacks proton, those at 36.14 
ppm and 63.11 ppm were methylene groups 
while the other nine peaks bears one hydrogen 
each 71.73, 72.66, 74.55, 78.02, 78.13, 96.86, 
101.59, 127.85 and 140.65 ppm. 
The heteronuclear multiple bond 
quantum coherence (HMQC) spectra showed 
correlations between the proton at 5.512 ppm 
and the carbon at 157.26 ppm. This carbon 
also resonates with the peak at 4.913 ppm. 
The heteronuclear multiple bond coherence 
(HMBC) spectrum revealed strong long 
range-correlations between proton at 5.491 
ppm and carbon at 127.85 ppm, this proton 
equally interacted with the carbon at 118.20 
ppm. Weak interactions were noted between 
proton at 5.491 ppm with the carbon at 74.55 
ppm as well as carbon at 157.26 ppm. The 
NOESY spectra showed that proton at 4.373 
ppm interacted very well with proton at 6.202 
ppm while the proton at 4.913 ppm showed 
interaction with that 4.571 ppm. Others were 
observed between 4.571 and 2.252 ppm; 2.033 
ppm.   
 
Bacterial susceptibility pattern of sub-
fractions D and compound I 
The results of the bacterial 
susceptibility pattern of the n-butanol column 
fraction D and its sub-fraction at the dose of 
0.3125 mg/hole are presented in Table 1. The 
activities ranged from 11.83 ± 0.17 to 19.00 ± 
0.00 among the organisms tested. Table 2 
shows the susceptibility pattern of D2-8 and 
compound I. Least activity of 13.33 ± 0.33 
was exhibited by sub-fraction D2-8 at 
concentration of 0.156 mg/hole against B.
subtilis while the highest activity was 
expressed by the same sub-fraction but at 
0.625 mg/hole against S. dysenteriae. The 
sensitivity indices namely the activity index, 
bacterial susceptibility index, spectral 
intensity index and average percent of 
bacterial susceptibility   were shown on Table 
3a, 3b. 









Figure 1: Compound I: (4S, 6R)-(Z)-6-(β-D-glucopyranosyloxy)-4-hydroxy-2-cyclohexenyl-
∆




Table 1: Effects of column fraction D and sub-fractions of the n-butanol portion of the stem bark of 
B. rufescens on some bacteria at 0.3125 mg/hole. 
 
Bacteria/diameters of Inhibition zone (mm)  
S/No 
   
Fractions  
B. subtilis  Corynaeb. spp.  E. coli  S. dysenteriae  
1  NBD 11.83 ± 0.17a  13.17 ± 0.17a 11.50 ± 0.29a  14.33 ± 0.17a  
2  D1  16.33  ± 0.33b  16.67 ± 0.17b  15.33 ± 0.33b,c  17.17 ± 0.60b  
3  D2-8  16.67 ± 0.33b  16.33 ± 0.33b  16.33 ± 0.33b  19.00 ± 0.00b  
4  D9-11  15.67  ± 0.33b  14.33 ± 0.33b  17.67 ± 0.17d  17.67 ± 0.67b  
5 D12-18  16.67  ± 0.88b  15.33 ± 0.33b  14.33 ± 0.33b  17.67 ± 0.33b  
6 Ciprofloxacin  
(5 µg/disc) 
25.33 ± 0.33c  36.00 ± 1.00c  26.67 ± 0.67e  20.00 ± 0.00b,c  
7 Erythromycin  
(5 µg/disc) 
23.67 ± 0.67c  33.00 ± 0.00d  28.33 ± 0.33f  19.83 ± 0.17b,c  
8  Gentamicin  
(10 µg/disc)  
24.33 ± 0.33c  22.33 ± 1.36e  14.00 ± 0.00b 17.33 ± 0.67b  
Key: Means with different superscript along same column are statistically different (P<0.05); NBD = n-butanol 
column fraction D. Data are presented as mean ± SEM, n = 3. 
 





Table 2: Effects of compound I and column fraction D2-8 of the n-butanol portion f the stem bark 
of B. rufescens on some bacteria at various doses. 
 
Bacteria/diameters of inhibition zone (mm) S/No  Dose (mg/hole)  
B. subtilis  Corynaeb. spp.  E. coli  S. dysenteriae  
1  D2-8 
(0.625)    
17.17 ± 0.17a,b  16.67 ± 0.33a  18.33 ± 0.33a  19.67 ± 0.33a 
2  Compound I 
(0.625) 
17.33 ± 0.67b  15.33 ± 0.33a  17.33 ± 0.33a  17.33 ± 0.33b  
3  D2-8  
(0.313)  
16.67 ± 0.33b,c  16.33 ± 0.33a  16.33 ± 0.33b  19.00 ± 0.00a  
4  Compound I  
(0.313) 
14.33 ± 0.33c  16.83 ± 0.33a  18.33 ± 0.33a  14.33 ± 0.88d  
5  D2-8  
(0.156 )  
13.33 ± 0.33c  17.67 ± 0.33a  14.67 ± 0.17c  17.67 ± 0.17c  
6  Ciprofloxacin  
(5 µg/disc) 
25.33 ± 0.33d  36.00 ± 1.00b  26.67 ± 0.67d 20.00 ± 0.00a  
7  Erythromycin  
(5 µg/disc) 
23.67 ± 0.67d  33.00 ± 0.00c  28.33 ± 0.33e 19.83 ± 0.17a  
8  Gentamicin  
(10 µg/disc)  
24.33 ± 0.33d  22.33 ± 1.36d  14.00 ± 0.00c 17.33 ± 0.67c 
Key: Means with different superscript along same column are significantly different (P<0.05). Data are presented as 
mean ± SEM, n = 3 
 
Table 3a: Activity and bacterial susceptibility indices of compound I, fraction D and sub-fractions 
of the n-butanol portion of the stem bark of B. rufescens on some bacteria.  
 
Activity index (%)  
 
Fractions  B. subtilis Coryneab. spp. E. coli S. dysenteriae 
D  a60.76  b65.02  a41.36  b45.12  a54.14  c103.14  a75.30  c86.90  
D1  a64.47  b68.99  a46.31  b50.52  a57.48  c109.50  a85.85  c99.08  
D2-8  a62.07  b66.41  a46.91  b51.18  a61.03  a116.29  a93.89  c108.37 
D9-11  a61.86  b66.20  a39.81  b43.42  a66.24  c126.21  a88.33  c101.96 
D12-18  a65.81  b70.43  a42.58  b46.45  a53.73  c102.36  a88.35  c101.96 
Compound I  a62.50  b66.88  a44.67  b48.73  a66.89  c127.36  a79.15  c91.34 
*BSI (%)  79.17  87.50  79.17  91.67  
Key: Activity index when computed with: a=Ciprofloxacin; b=Erythromycin; c=Gentamicin; * ≥15mm (DIZ) as the 
susceptible value. 
  





Table 3b: Percent activity and average percent of bacterial susceptibility of compound I, fraction D 
and sub-fractions of the n-butanol portion of the stem bark of B. rufescens on some bacteria. 
 









G+ve G-ve %T 






D1  100  100  100  14.60b  
D2-8  83.33  83.33 83.33 15.09c  
D9-11  100  100  100  14.57b  
D12-18  100  66.67  83.34  14.27a  
Compound I  83.33 75.00 79.17  14.62b  
Key: G+ve = Gram-positive; G-ve = Gram-negative; T= total, *values with different superscript along same column are 




The structure of compound I was 
elucidated and characterized using the 
analytical techniques. In structure elucidation 
of cyanogenic compounds, the Infra-red (IR) 
spectrum is a diagnostic tool that is expected 
to reveal strong nitrile absorption as a result of 
significant dipole moment associated with the 
CN bond leading to a significant change when 
it interacts with IR radiation usually appearing  
as an intense sharp peak at 2200- 2280 cm-1. 
In fact, very few other groups absorb at this 
region with this intensity and also together 
with a C=C stretching vibrations at 1620 cm-1 
(Eudea et al., 1983). The nitrile group is a 
reliable functional group that is generally easy 
to identify. From the IR spectrum, the 
following wave numbers were observed and 
assigned accordingly: 3359 cm-1 (-OH(str. -HB)), 
2954 cm-1-CH2(vasy); 2845 cm
-1(-CH2(vsym); 
2224 cm-1(-CN); 1637 cm-1 (-C=C (vstr.); 1457 
cm-1 (-CH(bend[rocking])); 1424 cm
-1 (-C=C(bend 
[scis])); 1018 cm
-1 (-C-O(str));  (Takahashi et al., 
1978; Seigler et al., 2005). Worthy of note is 
the broad band between 1099.8-1029.4 cm-1 
indicative of the glycosidic character of the 
compound (Tang et al., 2003). The UV 
absorption maximum at 259.0 nm suggests the 
presence of αβγδ-unsaturated nitrile group 
(Dwuma-Bada et al., 1976; Takahashi et al., 
1978; Seigler et al., 2005). 
The HNMR spectrum confirms the 
presence of a glucosyl group in compound I as 
shown  by the presence of a doublet signal at 
4.571 ppm (J=7.5 Hz, H-1́), a series of 
doublet-like signals centered at 3.336, 3.394, 
3.287, 3.663, 3.881 and 3.336 (H-5ʹ, H-3́ , H-
4ʹ, H-6́b, H-6́a, H-2́) are strong signals for 
sugar protons. The large overlap of double 
doublets between 3.306 and 3.336 ppm are 
indicative of glucose moiety. Two vinyl 
doublets appears at 6.289 (H-2) and 6.202 (H-
3) ppm and additional vinyl proton (α-H) at 
5.512 ppm. Two other protons are on carbon 
bearing hydrogen: doublet at 4.913 and 4.371 
{H-6ax, 4ax}. The two geminally available 
protons appeared at 2.252 and 2.033 ppm {H-
5eq and H-5ax} respectively corresponding to 
the methylene protons. The absence of singlet 
at δ3.70–3.90 ppm is indicative of the relative 
absence of methoxyl group, similarly no peak 
was observed between δ0.80-1.20 ppm 
characteristics of Rhamnose sugar (Mabry et 
al., 1970; Manguro et al., 2005) and hence the 
absence of these molecules. The COSY 
spectrum showed the H-H couplings; there is 
long range interactions observed between the 
protons, H-H coupling shows some definitive 





information about the aglycone moiety of 
compound I. The unique coupling at 4.371 (H-
4ax) is found coupled to up field protons at 
2.033 and 2.252 ppm ({H-5ax and H-5eq} and 
equally to the three vinyl protons (H-α,2,3). 
The vinyl proton at 5.512 ppm is coupled to 
the two other vinyl protons as well as to the 
peaks centered at 4.913 and 4.371 ppm H-6ax, 
4ax ppm which is line with earlier reports by 
Jaki et al. (2003) and Seigler et al. (2005). The 
multiplicities and couplings observed on the 
aglycone are as follows: α-H[ 5.512 ppm], d, 










=3.0 Hz; 4ax-H[4.371 
ppm], m, J=12.0 Hz; 4eq-OH[4.753 
ppm{acetone}], d{broad}, J4-OH,4=6.2 Hz; 5eq-





















=1.5 Hz. The 
couplings due to sugar protons showed 
multiplicities: 1′-H[4.571 ppm], d,=7.5 Hz; 2́-
H[3.336 ppm], dd, J2ʹ,3́=9.0 Hz, J2ʹ,1́=6.5; 2′-
OH[4.956 ppm{acetone}], dd, J
2′-OH, 2′
=3.0 Hz; 
4ʹ-H[3.287 ppm], dd, J4ʹ,3́= J4ʹ,5́=9.5 Hz; 4′-
OH[4.939 ppm{acetone}], d, J
4′-OH,4′
=3.0 Hz; 
3ʹ-H[3.394 ppm], dd, J3ʹ,2́= J3ʹ,4́=8.5 Hz; 3′-
OH[4.945 ppm{acetone}], d, J
3′-OH,3′
=2.5 Hz; 
5ʹ-H[3.336 ppm], ddd, J5ʹ,4́=9.0 Hz, J5ʹ,6á=6.5 
Hz, J5ʹ,6b́=2.0 Hz; 6á-H[3.663 ppm], dd, 
J6á,6b́=12.0 Hz, J6á,5́=6.0 Hz; 6b́-H[3.881 
ppm], dd, J6b́,6á=12.0 Hz, J6b,́5ʹ=2.0 Hz and 6′-
OH[4.520 ppm{acetone}], d, J6′-OH,6′b=11.5 
Hz, J6′-OH,6′a=8.0 Hz. 
The 13CNMR spectrum of the 
compound I in methanol exhibited fourteen 
carbon atoms approximately equal in height 
with some having characteristic chemical 
shifts equivalence. The presence of peak at 
101.59 is typical of anomeric carbon of 
glucoside (C-1́); other doublet peaks at 78.02, 
78.13, 72.66, 71.73 and 63.11 ppm supported 
the fact that the compound contained β-
glucopyranose moiety (Pauli, 1993; Seigler et 
al., 2005) and the presence of singlet peak at 
118.20 ppm is assignable to the αβ- 
unsaturated nitrile carbon (Eudea et al.,1983; 
Seigler et al., 2005). Other signals at 36.14 
ppm (a methane or methylene carbon, C-5) 
65.42 and 74.55 ppm (carbon bearing oxygen; 
C-4 and C-6 respectively) while the signal at 
96.86, 127.85, 140.65 and 157.26 ppm 
(aromatic or vinyl carbons; α-C, C-3, C-2, C-1 
respectively). The  DEPT spectrum revealed 
that the peaks at 157.26 ppm (C-1) and 118.20 
ppm (CN) lack protons, those at 36.14 ppm 
(C-5) and 63.11 ppm (C-6ʹ) are methylene 
groups while the other nine carbons bear one 
hydrogen [α-C(96.86), C-2(140.65), C-
3(127.85), C-6(74.55), C-1ʹ( 01.59), C-
2ʹ(72.66), C-3́(78.02) C-4́(71.73) and C-
6ʹ(78.13)]. 
The heteronuclear multiple bond 
quantum coherence (HMQC) spectra showed 
that there were interactions between the 
proton at 5.512 ppm (H-α) and the vinyl 
carbon at 157.26 ppm (C-1), the carbon of the 
proton resonating at 4.913 ppm (H-6), the 
nitrile carbon and the sugar anomeric carbon, 
suggest that these groups are proximal in the 
structure. Because the methylene group 
protons at 2.252 and 2.025 ppm (H-5eq, 5ax) 
are coupled both to the proton at 4.371 ppm 
(H-4ax) and that at 4.913 ppm (H-6), a six 
membered ring is required (Seigler et al., 
2005). The heteronuclear multiple bond 
coherence (HMBC) spectrum revealed strong 
long range-correlations between proton at 
5.491 ppm (H-α) and carbon at 127.85 ppm 
(C-2) suggestive of cis-relationship, the 
proton equally interacted with the nitrile 
carbon at 118.20 ppm suggesting that this 
proton and the nitrile group are attached to the 
same carbon atom. The signal 5.491 (H-α) 
also interacted weakly with the oxygen-
bearing carbon at 74.55 ppm (C-6) and the 
vinyl carbon at 157.26 ppm (C-1). There is a 
strong interaction of this proton (H-α) with the 
anomeric carbon (C-1ʹ) at 101.59 ppm which 
suggests that the site of attachment of the 
sugar is on the carbon at 74.55 ppm (C-6) 
(Takahashi et al., 1978; Seigler et al., 2005). 





The NOESY experiment is designed to 
reveal the kind of protons that are closer in 
space showed that the proton at 4.373 ppm 
(H-4) has an interaction with the vinyl proton 
at 6.202 ppm (H-3) while the proton at 4.913 
ppm (H-6) interacted favourably with the 
anomeric proton at 4.571 ppm (H-1ʹ). Closer 
interactions between the anomeric proton 
{4.571 ppm (H-1́)} with the up field protons 
at 2.252 ppm (H-5eq) and also 2.033 ppm (H-
5ax) were observed. The mass spectra showed 
base peak at 314.1243 [M+H]+ while the 
glucose fragmentation appeared at M+ 
152.0715 when run with an internal standard  
{[Glu]-Fibrinopeptide B}. According to 
Takahashi et al. (1978), the mass spectra of 
the nitrogen containing compound mostly had 
an even numbered M+H value in electron 
impact mode and therefore suggestive of 
nitrogenous compound. Consistently, the 
accurate mass measurement of compound I 
showed M/Z peak at 313.1243 which is in a 
closer proximity to the isotopic theoretical 
value of M/Z peak 313.1240. Therefore, taken 
collectively the spectral information suggested 
a planar conjugated system with two double 
bonds, a nitrile group, a glucose moiety and 
an oxygen-bearing carbon at 4.371 ppm (H-
4ax). Furthermore, the proton at 5.512 ppm 
(H-α) is in cis-relationship to one of the vinyl 
carbons. Based on the 13CNMR and mass 
spectral data, the molecular formula requires 
six sites of unsaturation, hence a ring in both 
the sugar and the aglycone portion of the 
compound. Though, the structure of 
compound I was established earlier (Sosa et 
al., 1977; Takahashi et al., 1978; Nahrstedt 
and Wray, 1990; Seigler et al., 2005) as 
Menisdaurin; it is indeed, the first time the 
compound is run in acetone to confirm the 
OH-configurations on the compound in 
relation to the earlier use of the DMSO by 
Takahashi et al. (1978). In line with the newer 
technologies in structure elucidation (HMBC, 
HMQC, NOESY), the spectral data of the 
isolated compound as shown by the 
conformational and structural configuration as 
C14H19NO7 conforms well with the 
compound’s spectra data reported earlier by 
Seigler et al. (2005) as: (4S, 6R)-(Z)-6-(β-D-
glucopyranosyloxy)-4-hydroxy-2-
cyclohexenyl-∆1,α-acetonitrile–a cyclohexenyl 
cyano methylene structure shown in the Figure 
1 below. 
Menisdaurin was considered non-
cyanogenic (Nahrsredt and Wray, 1990; 
Yamasaki, 1997) and was later noted to 
liberate small amount of cyanide by sandwich 
method of TLC (Seigler et al., 2005) and also 
under certain conditions there has been reports 
that cyanogenic glycosides with nitrile group 
alpha to the glycosidic linkage have been 
known to liberate HCN upon hydrolysis 
(Lechtenberg and Nahrstedt, 1999; Yamasaki, 
1997). However, the mechanisms of cyanide 
liberation from Cyanogenic glycosides with 
nitrile group (example menisdaurin, 
ehretioside B) not adjacent to the glycosidic 
linkage still remain unknown (Yamasaki, 
1997).  
The susceptibility pattern shown on 
Table 1 revealed that wider diameters of 
inhibition zones (DIZ) of 16.67 mm were 
expressed against Gram-positive bacteria - B.
subtilis (D2-8, D12-18) and 
Corynaebacterium spp. (D1). However, lower 
DIZ was found as 14.33 mm against 
Corynaebacterium spp. which was indeed 
higher than the value expressed by n-butanol 
portion at same dose (Usman et al., 2009b). 
The effects on Gram-negative bacteria were 
expressed by D2-8 with higher activity of 
19.00 mm against S. dysenteriae while 14.33 
mm was observed as the lowest DIZ 
expressed by D12-18 against E. coli. 
The results on Table 2 below revealed 
high activity against B. subtilis at 0.625 
mg/hole expressed by compound I; the least 
value of 14.33 mm was however exhibited by 
D2-8 against same bacteria. 
The bacterial activities indices shown 
on Table 3a,b indicates high activity index of 
65.81% and 70.43% when computed with 
Ciprofloxacin and Erythromycin against B. 
subtilis and the least value of 39.81% and 
43.42% when computed similar antibiotics 





against Corynaebacterium spp. More so, the 
AI against Gram-negative bacteria had higher 
percentage of 93.89% when computed with 
Ciprofloxacin and Gentamicin against S. 
dysenteriae. However, compound I had AI of 
66.89% and 127.36% when computed with 
Ciprofloxacin and Gentamicin against E. coli; 
suggesting compound I being a better agent 
compared to Gentamicin against this notorious 
bacteria. The BSI indicated high percentage 
value of 91.67% against S. dysenteriae while 
79.17% was lowest against E. coli and B. 
subtilis. The percentage activity varied from 
66.67-100% against both Gram-positive and 
Gram-negative bacteria. The SII showed D2-8 
having high value of 15.09 mm while 
compound I followed with a value of 14.62 
mm, expressing the compound being very 
active (Usman et al., 2007), and the APBS 
was higher towards Gram-positive bacteria 
with 93.33%. This trend explains the efficacy 
of fraction D2-8 and compound I. These 
susceptibility patterns were similar to those 
reported earlier (Parekh et al., 2006; Usman et 
al., 2007; Geidam et al., 2007). 
 Although cyanogenesis was earlier 
reported in Fabaceae (Caesalpinioideae), this 
is the first report on the isolation and 
characterization of cyanogenic glucoside 
(menisdaurin) from the species B. rufescens as 
well as the bioassay directed antibacterial 
effects against some bacterial strains i  vitro. 
This study therefore showed that menisdaurin 
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